Obzidan - drugs used in cardiology.
Obzidan having antiarrhythmic action reduces pressure eliminates symptoms of coronary heart disease, reduces the frequency of contractions of the heart, cardiac muscle demand for oxygen and cardiac output value.
The active ingredient of the drug - propranolol hydrochloride.
Obzidan release tablets.
The drug is prescribed for sinus and supraventricular tachycardia, unstable angina and angina, hypertension, atrial tachyarrhythmias, ventricular and supraventricular arrhythmia, essential tremor.
There are reviews Obzidane successfully used to prevent a heart attack when blood pressure greater than 100 mm Hg. Art.
Also drug effectively prevents migraine applied in thyrotoxicosis - in those cases where it is impossible to apply the standard treatment thyreostatics.
Instructions obzidan: how to use
For the treatment of hypertension drug take 80 mg a day in 2 divided doses. If the pressure is not reduced, the dosage was increased to 120 or 160 mg. More than 320 mg per day can not be taken.
For the prevention of migraine, essential tremor when taking 120 mg obzidan.
When cardiac arrhythmias, for the treatment of angina is a daily dosage of 60 mg. After a while it was raised to 80-120 mg. Take the tablets in two or three doses. Permitted dosage for these states - 240 mg.
After a heart attack, in order to avoid relapse, from the 5 th to 21 th day after the attack recommends taking obzidan. Prescribe medication at a dose of 120 mg, take it within 2-3 days. Thereafter, the dosage is reduced to 80 mg.
For the symptomatic treatment of hyperthyroidism drug is prescribed to take a dosage of 120-160 mg.
The instructions obzidan indicated that patients with abnormalities of the kidney or liver disease should not take the drug at the standard scheme. For these patients the dose of propranolol reduced.
Application obzidan can cause heart failure, sinus bradycardia, conduction disturbances infarction, orthostatic hypotension, arrhythmia, abnormal liver function, thyroid, exacerbation of psoriasis, the appearance of dry mouth, muscle weakness, chest pain, joint pain and back pain, skin rashes, shortness of breath, nasal congestion, nausea, constipation, diarrhea, change in taste.
There are reviews Obzidane causing patients headache, drowsiness, depression, confusion, dizziness, weakness, fatigue, agitation, tremor of limbs, hallucinations, a brief memory loss, blurred vision, potency and libido.
Under the influence of the drug may develop leukopenia, agranulocytosis, thrombocytopenia.
Do not prescribe the drug for sinus bradycardia, congestive heart failure, cardiogenic shock, sinoatrial blockade, acute myocardial infarction, pulmonary edema, Prinzmetal angina, cardiomegaly, asthma, diabetes, vasomotor rhinitis, spastic colitis, pheochromocytoma, metabolic acidosis.
The instructions obzidan stated that it can not be combined with MAO inhibitors, antipsychotics, trioxazine, hlopromazinom and other anxiolytics.
The drug is contraindicated for pregnant women, breastfeeding women.
Under the supervision take obzidan patients in the elderly, children under 18 years of age, patients with hepatic or renal insufficiency, myasthenia gravis, chronic heart failure, psoriasis, hyperthyroidism, AV-blockade of the first degree.